Add to ORKGA binding site for the thromboxane A2/prostaglandin H2 (TXA2/ PGH2) antagonist 611-dimethylmethano-1 1,1 2-methano-1 6-(3-iodo-4-hydroxyphenyl)-1 3,1 4-dihydro-1 3-aza-1 5af3-w-te-tranor-TXA2 to washed human platelets was studied. 9,1 1-Di
We investigated the cause of mild mucocutaneous bleeding in a 14-year-old male patient (P1). Platele...
ABSTRACT Despite numerous suggestions in the literature that thromboxane A2 is involved in a variety...
A patient with a mild bleeding disorder whose platelets responded defectively to thromboxane A_2 (TX...
Thromboxane A2 (TXA2) and prostaglandin H2 (PGH2) may aggregate platelets via a common membrane rece...
Thromboxane A2 (TXA2) is a potent platelet aggregating agent and constrictor of coronary, vascular,...
AbstractIn this study, we have demonstrated for the first time by using U 46619, a stable analogue o...
AbstractThe present study investigated the mechanism by which eicosapentaenoic acid (EPA) and docosa...
Thromboxane A(2) (TXA(2)) and 8-iso-PGF(2 alpha). are two prostanoid agonists of the thromboxane A(2...
Platelets have been implicated in the formation of occlusive intracoronary thrombi leading to unstab...
Thromboxane A2 (TxA2) is a potent platelet agonist that serves as an amplifying signal after exposur...
Thromboxane (TX) A2 and prostaglandin (PG) D2 mediate opposing actions in platelets and in vascular ...
Binding and function of BMS 1 80,291 [(+)1S-(1 a,2a,3a,4a)]-2-[[3-[4-[(n-pentylamino)carbonyl]-2-oxa...
AbstractA photoactive iodoarylazide derivative (I-APA-PhN3) of the competitive thromboxane A2/prosta...
While blood platelets express several G-protein-coupled receptors (GPCRs) that play pivotal roles in...
The thromboxane (Tx) A2 pathway is a major contributor to the amplification of the initial platelet ...
We investigated the cause of mild mucocutaneous bleeding in a 14-year-old male patient (P1). Platele...
ABSTRACT Despite numerous suggestions in the literature that thromboxane A2 is involved in a variety...
A patient with a mild bleeding disorder whose platelets responded defectively to thromboxane A_2 (TX...
Thromboxane A2 (TXA2) and prostaglandin H2 (PGH2) may aggregate platelets via a common membrane rece...
Thromboxane A2 (TXA2) is a potent platelet aggregating agent and constrictor of coronary, vascular,...
AbstractIn this study, we have demonstrated for the first time by using U 46619, a stable analogue o...
AbstractThe present study investigated the mechanism by which eicosapentaenoic acid (EPA) and docosa...
Thromboxane A(2) (TXA(2)) and 8-iso-PGF(2 alpha). are two prostanoid agonists of the thromboxane A(2...
Platelets have been implicated in the formation of occlusive intracoronary thrombi leading to unstab...
Thromboxane A2 (TxA2) is a potent platelet agonist that serves as an amplifying signal after exposur...
Thromboxane (TX) A2 and prostaglandin (PG) D2 mediate opposing actions in platelets and in vascular ...
Binding and function of BMS 1 80,291 [(+)1S-(1 a,2a,3a,4a)]-2-[[3-[4-[(n-pentylamino)carbonyl]-2-oxa...
AbstractA photoactive iodoarylazide derivative (I-APA-PhN3) of the competitive thromboxane A2/prosta...
While blood platelets express several G-protein-coupled receptors (GPCRs) that play pivotal roles in...
The thromboxane (Tx) A2 pathway is a major contributor to the amplification of the initial platelet ...
We investigated the cause of mild mucocutaneous bleeding in a 14-year-old male patient (P1). Platele...
ABSTRACT Despite numerous suggestions in the literature that thromboxane A2 is involved in a variety...
A patient with a mild bleeding disorder whose platelets responded defectively to thromboxane A_2 (TX...